baber/WOPTO huggingface dataset:
Patent FI-905415-A0 (FI)
Inventor: METZEMACHER HANS-DIETER
IPC: C08K3/22
Filed: 1990-11-01
Abstract: Surface-modified magnesium hydroxides and aluminum hydroxides, which are employed as flame-inhibiting fillers in thermoplastic polyolefins.
Patent FI-906071-A0 (FI)
Inventor: GOTTO JOHN WILLIAM
IPC: A61K39/00
Filed: 1990-12-10
Abstract: A process for extracting and purifying a protein having an apparent molecular weight of about 69,000 daltons from the outer membrane of the bacterium Bordetella pertussis is provided. The process includes inactivating Bordetella pertussis cells with a bacteriostatic agent, repetitive extraction, and purification of the 69,000 dalton protein from extract by dye ligand chromatography followed by chromatofocusing. The process results in improved yield and stability of the 69,000 dalton protein.
Patent FI-916004-A0 (FI)
Inventor: LETEMPS BERNARD
IPC: C03B23/03
Filed: 1991-12-19
Abstract: Method and apparatus for bending a glass sheet in which the glass sheet is conveyed through a reheating furnace by a conveyor defining a substantially horizontal transport plane and is then taken up by a tool by means of which the glass sheet is bent and/or transferred to a bending and/or discharging device. 
<??>According to the invention the measurement of the detection of the effective position of the glass sheet and the repositioning of the take-up tool are performed as a function of the said effective position. 
<??>The invention applies to the production of motor vehicle glazing. 
<IMAGE>
Patent FI-920111-A0 (FI)
Inventor: TERNANSKY ROBERT JOHN
IPC: A61P31/04
Filed: 1992-01-10
Abstract: An antibacterial compound of the formula <CHEM> wherein R is hydrogen, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C3-C6 cycloalkyl, or C1-C6 haloalkyl; A and A min  are independently hydrogen, C1-C6 alkyl, nitro, amino, C1-C6 alkoxy, a 5-6 membered heterocycle containing nitrogen or sulfur, or phenyl; or A and A min taken together form a group of the formulae <CHEM> wherein X is hydrogen, halo, C1-C6 alkyl, C1-C6 alkoxy, C1-C6 alkoxycarbonyl, amino, nitro, or carboxy; and Y is nitrogen or carbon; or a pharmaceutically acceptable salt thereof.
Patent FI-924198-A0 (FI)
Inventor: SALIN HANNU-PEKKA
IPC: H04W4/14
Filed: 1992-09-18
Abstract: PCT No. PCT/FI93/00373 Sec. 371 Date May 9, 1995 Sec. 102(e) Date May 9, 1995 PCT Filed Sep. 17, 1993 PCT Pub. No. WO94/07338 PCT Pub. Date Mar. 31, 1994A method for starting a short message transmission in a cellular radio network, a corresponding cellular radio network, and a subscriber register for a cellular radio network. The subscriber register is equipped for sending a short message transmission start message to at least one short message service centre. For delaying start messages for short message transmission for a given subscriber, the subscriber register includes a memory, a control, a transmitter responsive to the control for sending start messages for short message transmission for a given subscriber to different short message service centres after delays of variable duration, and a delay producer, responsive to the transmitter, generating a variable delay for delaying sending of start messages for short message transmission for a given subscriber by the transmitter for a desired period of time.
Patent FI-934513-A0 (FI)
Inventor: ALLONEN HANNU
IPC: A61M5/31
Filed: 1993-10-13
Abstract: The surface (21) of the plunger and the inner wall (15) of the implant housing are equipped with interacting members (22,12) which allow the plunger to be pushed inwards into the implant housing while preventing the removal of the plunger from the implant housing. The cannula is made of plastic. The surface of the plunger is equipped with a member (22) which allows the displacement of the plunger inwards into the implant housing and that the rim or edge (12) of the implant housing distal to the cannula is shaped so that the inner cross-sectional area of the implant housing is reduced at point (16). The edge acts as a stop for the element on the surface of the plunger when the plunger is displaced outwards.
Patent FI-935498-A0 (FI)
Inventor: CAO YONG
IPC: C08G73/02
Filed: 1993-12-08
Abstract: Compositions of electrically conductive substituted and unsubstituted polyanilines in nonconductive substrates such as polymers or polymer plus solvents with protonic acids are disclosed as are methods of forming such compositions and use of same to form conductive articles.
Patent FI-941106-A0 (FI)
Inventor: FRITZ HUBERT
IPC: E04B2/70
Filed: 1994-03-09
Abstract: The wall comprising bars, planks, boards or the like has a seal which is formed by a sheeting strip (1). Said sheeting strip (1) is laid in the gap (2) which is provided in the case of a groove-and-tongue connection comprising the cutout (3) and the protrusion (4). The sheeting strip bears in an elastic manner on the walls of the gap. <IMAGE>
Patent FI-941549-A0 (FI)
Inventor: KEMPPI KYOESTI
IPC: B65H67/052
Filed: 1994-04-05
Abstract: PCT No. PCT/FI95/00182 Sec. 371 Date Oct. 1, 1996 Sec. 102(e) Date Oct. 1, 1996 PCT Filed Apr. 4, 1995 PCT Pub. No. WO95/26923 PCT Pub. Date Oct. 12, 1995A method and arrangement in connection with a continuously operating spooler is provided, in which the thread to be spooled is arranged to be guided onto an empty reel after a first reel has become full by means of a moving finger and a gripper rotating with the empty reel. The thread to be spooled is moved using the finger, into the path of the gripper. The movement of the thread carried out by means of the finger is synchronized with the movement of the gripper in such a manner that the finger manages to move the thread into the path of the gripper before the gripper reaches the meeting point of the gripper and the thread.
Patent FI-951836-A0 (FI)
Inventor: FRIEBE ROBERT
IPC: C07F7/18
Filed: 1995-04-18
Abstract: The novel feature in the reaction of polysiloxanes with alkoxysilanes is that fluoride ions are present as activator, such ions pref. having as their source: (i) an alkali metal fluoride; or (ii) a non-metallic cpd. esp. a tetra-alkylammonium fluoride and/or NH4F as well as trialkylamine-HF and other polyhydrofluorides or tert. org. amines.
Patent FI-972191-A0 (FI)
Inventor: BOLLI PETER
IPC: A63H3/44
Filed: 1997-05-22
Abstract: PCT No. PCT/EP95/04569 Sec. 371 Date May 21, 1997 Sec. 102(e) Date May 21, 1997 PCT Filed Nov. 20, 1995 PCT Pub. No. WO96/15839 PCT Pub. Date May 30, 1996Threads of hair are embroidered in loops on a flat, flexible base, for example, a textile base, in an area bounded by a desired wig contour. Individual threads or tufted multiple threads are embroidered in loops. Thereafter, the embroidered area is removed from the base along with the wig contour by cutting or punching. The flexible wig is glued onto a doll's head, cut to length and combed.
Patent FI-982251-A0 (FI)
Inventor: LUNDELL ANTERO
IPC: H04W48/08
Filed: 1998-10-16
Abstract: A method for performing cell re-selection in a cellular network includes a subscriber terminal measuring received powers of neighbour cells in accordance with system information received from a current cell, selecting one of the neighbour cells as a new cell, the subscriber terminal receiving a part of the system information sent by the new cell, calculating the time used for receiving the system information of the new cell by employing the length information in the system information part sent by the new cell, and deciding whether to continue the re-selection of said new cell on the basis of the calculated time.
Patent AP-9801373-A0 (AP)
Title: The basic coffin.
Inventor: HARDINE JAMES P
Filed: 1998-10-30
Abstract: The two lenghts are attached about 350mm apart, and are at the place where the main body weight will be in the coffin. Thus item 3 has these two straps attached. They are then threaded down the side and under the coffin base item 1], passing under the base then up the opposite side to be tightened and bolted/screwed tightly so that the base has three straps undeaneath for strenght. This new method of manufacturing a coffin gives the way to using thinner board/sheet materials.
Patent IL-71314-A0 (IL)
Title: Chromone-and thiochromone-substituted 1,4-dihydropyridine-lactones,their preparation and pharmaceutical compositions containing them
IPC: A61P3/08
Filed: 1984-03-22
Abstract: Dihydropyridines of the formula   <IMAGE>   in which R1, R2, R5 and R6 can be hydrogen or various halogen or organic radicals, R4 is an optionally substituted hydrocarbon radical, A is a direct bond, a C1-C20-alkylene chain or a C2-C20-alkenylene chain, which chains are optionally interrupted by O or S X is O or S, and Y is a direct bond, O, S, -NH-or-N-alkyl with 1 to 8 C atoms or a pharmaceutically acceptable salt, are useful as cardiotonic agents for improving heart contractility, antihypotonic agents, for lowering the blood sugar level, for detumescing mucous membranes and for influencing the salt and/or liquid balance.
Patent IL-83026-A0 (IL)
Title: Amide derivatives
IPC: C07C237/22
Filed: 1987-06-30
Abstract: The invention concerns novel phenoxyacetic acid amide derivative of the formula I <CHEM> (and pharmaceutically acceptable salts thereof) in which R<1> is hydrogen or fluoro, R<2> is phenyl, cyclo-alkyl, alkyl or alkenyl as defined herin, and R<3> is hydrogen, methyl or ethyl, or R<2> and R<3> together form polymethylene as defined herein. The invention also includes pharmaceutical compositions containing the amide derivatives, means for the manufacture of the said derivatives and for their use in the treatment of obesity and related conditions and/or in the manufacture of novel medicaments.
Patent IL-94530-A0 (IL)
Title: Interleukin-7 receptors,their production and pharmaceutical compositions containing them
IPC: C12N15/00
Filed: 1990-05-28
Abstract: Mammalian Interleukin-7 receptor proteins, DNAs and expression vectors encoding mammalian IL-7 receptors, and processes for producing mammalian IL-7 receptors as products of recombinant cell culture, are disclosed.
Patent IL-96574-A0 (IL)
Title: Process and intermediates for the preparation of phenylsulfonamides
IPC: C07F1/06
Filed: 1990-12-06
Abstract: 2-(2-Haloethylthio)phenylsulphonamides of the formula I 
<IMAGE>
 in which 
 
  R1 denotes hydrogen, C1-C5-alkyl or C2-C5-alkenyl; and 
  Z denotes hydrogen, fluorine or chlorine, are prepared by 
 
  A) converting a phenylsulphonamide of the formula II 
<IMAGE>
 in which 
 
  R1 has the meaning given in formula I and 
  Y represents a tertiary alkyl group having 4 to 8 carbon atoms, benzyl, diphenylmethyl, triphenylmethyl or a silyl group of the formula VII
 -Si(R2R3R4) (VII), 
 in which R2, R3 and R4, independently of one another, denote C1-C6-alkyl or phenyl, in succession without isolation of the intermediates into the compound of the formula III 
<IMAGE>
 in which Me, R1 and Y have the abovementioned meaning, using 
 
  a) a strong base of the formula IX
 MeB (IX),
 in which Me represents sodium or potassium, B represents hydrogen, OH, NH2 or OR5 and R5 represents C1-C5-alkyl, converting this compound into the compound of the formula IV 
<IMAGE>
 in which Me, R1 and Y have the abovementioned meaning, using 
  b) one equivalent of n-butyllithium and 
  c) sulphur,
 converting this compound to a phenylsulphonamide of the formula VI 
<IMAGE>
 in which Z and R1 have the meaning given in formula I and Y has the meaning given in formula II, using 
  d) a 2-halofluoroethane of the formula V
 X-CH2CHF-Z) (V) 
 in which X represents chlorine or bromine and Z has the meaning given in formula I, and 
  B) then cleaving off the group Y.
Patent SE-9601109-A0 (SE)
Title: Lödningsförfarande med användning av en konsumerbar trådelektrod
Inventor: PERSSON KJELL-ARNE
IPC: B23K35/38
Filed: 1996-03-22
Abstract: 2 En annan nackdel är att MIG-svetssommen är relativt hard och dart& erfordrar grovslipning fOr astadkommande av en jarrin fog. Ytskiktet skadas ocksa ofta av sadan grovslipning. MIG-svetsning är utfarligt beskriven I patentlitteraturen och sá- som exempel harivisas till EP-A-0 167 163 och GB-A-2 124 531. Nyligen har lOdningsforfaranden med anvandande av en konsumerbar elektrod utvecklats, exempelvis for att bygga upp ett tunt kopparytskikt pa ett substrat. HittiIls har sadana lOdningsforfa- randen endast genomforts manuellt. Tradmatningshastigheten, framfOringshastigheten och saledes den uppnadda deponeringshastigheten har varit relativt laga och darfor har dessa lodningsforfaranden inte varit lampliga fOr anvdndande i den hogproduk- tiva tillverkningsindustrin. DE-A-3 025 199 visar hardlOdning av tunna platdelar hos i synnerhet motorfordon medelst en konsumerbar, smaltande elektrod. Lad ningen ager rum i ett temperaturomrade mellan 950 och 1100 °C. Denna skrift anger inte vilken typ av ljusbage som ut- nyttjas. Sasom skyddsgas foreslas en ren argon, dvs endast en inert komponent. US-A-3 436 521 visar ett fOrfarande for lodning av tunna platde25 taljer vid tillverkning av bilar medelst en konsumerbar, smdltande elektrod. Denna skrift foreslar darvid anvandande av en bigsvetsapparat. Argon utnyttjas sasom skyddsgas. SAMMANFATTNING AV UPPFINNINGEN Andamalet med foreliggande uppfinning är att overvinna de ovan beskrivna problemen. I synnerhet syftar uppfinningen till att uppna ett forbattrat lOdningsfOrfarande for att fOrbinda speciellt relativt tunna metallplatar. Det är vidare ett dndarnal att uppna ett lOdningsfOrfarande som resulterar i en hog deponeringshastighet och i en stark ladsom.
Patent FI-20015033-A0 (FI)
Inventor: SEPPAELAE TEIJO
IPC: B60J7/08
Filed: 2001-10-29
Abstract: The invention relates to a vehicle deck cover device (6) for covering the load, which includes a supporting frame (7) in front of the deck, equipped with a lifting device, and mounted on the chassis (3) of the vehicle, a covering device (9) supported by this, and a scissors device (10) used to operate it. The covering device (9) preferably comprises a cover (11) rolled onto a transversely rotating roller (12).
Patent FI-20055700-A0 (FI)
Inventor: TAST NIILA
IPC: B65D88/76
Filed: 2005-12-23
Abstract: A container comprises a body (1) that is configured for underground installation. It may also comprise an ascending tube (2). The ascending tube may be detachable from the body and it may comprise a tube part (3) and a base whose outer dimensions are larger than the tube part (3) seen in the axial direction of the tube part. On the exterior of the body (1), at least on one side thereof, it is possible to arrange transport mounts (13).
Patent IL-100860-A0 (IL)
Title: 2,4-and 2,5-bistetrazolylpyridines,a process for the preparation thereof and the use thereof as pharmaceuticals
IPC: A61P7/02
Filed: 1992-02-03
Abstract: The invention relates to 2,4- and 2,5-bis(tetrazolyl)pyridines. The said compounds inhibit the enzymes proline hydroxylase and lysine hydroxylase and cause selective inhibition of collagen biosynthesis. They are used as fibrosuppressants and immunosuppresants.
Patent IL-101945-A0 (IL)
Title: Assay methods utilizing induced luminescence
IPC: G01N33/569
Filed: 1992-05-21
Abstract: Methods are disclosed for determining an analyte in a medium suspected of containing the analyte. <??>One method comprises providing in combination (1) a medium suspected of containing an analyte; (2) a label reagent comprising a suspendible particle and a first specific binding pair (sbp) member associated with a photochemically activatable chemiluminescent compound (PACC), wherein said first sbp member is capable of binding to said analyte or to a second sbp member, wherein said second sbp member is capable of binding to said analyte; and (3) an intrinsically metastable species capable of diffusing in said medium and of reacting preferentially with said PACC when said PACC is brought into close proximity to said species by virtue of the presence or absence of said analyte; and determining whether said intrinsically metastable species has reacted with said PACC, the reaction thereof being related to the amount of analyte in said medium.
Patent IL-104087-A0 (IL)
Title: Microcrystalline cellulose spheronization composition
IPC: C08L1/28
Filed: 1992-12-14
Abstract: A particulate co-processed unattrited microcrystalline cellulose:hydrocolloid composition wherein the respective components are present in a weight ratio of from about 99:1 to 70:30. The composition is useful as a spheronizing agent for producing spheroids of uniform size and sphericity and having high drug loadings. The composition is produced by drying a slurry of the microcrystalline cellulose in an aqueous solution of the hydrocolloid. The preferred hydrocolloid is methylcellulose.
Patent IL-109744-A0 (IL)
Title: 3-(indol-3-yl) propenoic acid derivatives and pharmaceutical compositions thereof
IPC: A61K31/535
Filed: 1994-05-24
Abstract: A compound of formula (I), wherein Z is hydrogen, -CH3, or -C2H5; X and Y are represented by -OH, a physiologically acceptable ester, or a physiologically acceptable amide; R is represented by from 1 to 3 substituents independently chosen from the group: hydrogen, C1-4 alkyl, C1-4 alkoxy, halogen, -CF3, or -OCF3; R1 is represented by from 1 to 3 substituents independently chosen from the group: hydrogen, amino, C1-4 alkyl, C1-4 alkoxy, halogen, -CF3, or -OCF3; and pharmaceutically acceptable addition salts thereof. These 3-indolyl-3-yl-propenoic acid derivatives are useful as NMDA antagonist.
Patent IL-110329-A0 (IL)
Title: Derivatives of imidazo(1,2,a) pyrazin-4-one, their preparation and medicaments containing them
IPC: C07D487/10
Filed: 1994-07-14
Abstract: Compounds of formula (I), wherein either R is C=R3, C(R4)R5 or CH-R6, R1 and R2 are hydrogen, halogen, alkyl, alkoxy, amino, acylamino, -NH-CO-NH-Ar, -N=CH-N(alk)alk', nitro, cyano, phenyl, imidazolyl or SO3H, R3 is oxygen, NOH, NO-alk-COOK or CH-R7, R4 is alkyl, -alk-Het or alk-Ar, R5 is alkyl, -alk-Het or -alk-Ar, or C(R4)R5 is cycloalkyl, R6 is hydroxy, alkyl, NR8R9, -alk-OH,-alk-NR8R9, -alk-Ar or -alk-Het, R7 is hydroxy, alkyl, phenyl, -alk-Ar, -alk-Het, NR10R11 or a heterocyclic ring, R8 and R9 are alkyl, or R8 is hydrogen and R9 is hydrogen or alkyl, -COR12, -CSR30 or -SO2R13, R10 and R11 are alkyl or cycloalkyl, R12 is alkyl, cycloalkyl, phenyl, -COO-alk, -CH2-COOX, -CH2-NH2, -NH-alk, -NH-Ar, -NH2 or -NH-Het, R13 is alkyl or phenyl, R30 is -NH-alk, -NH-Ar, -NH2 or -NH-Het; or R is a 2-imidazolylmethyl radical and each of R1 and R2 is a hydrogen atom. The compounds of formula (I) are  alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists, said receptor also being known as the quisqualate receptor. Furthermore, the compounds of formula (I) are non-competitive N-methyl-D-aspartate (NMDA) receptor antagonists, and especially NMDA receptor glycine modulation site ligands.
Patent IL-112572-A0 (IL)
Title: Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
IPC: A61K31/352
Filed: 1995-02-07
Abstract: Pharmaceutical compositions are described for preventing neurotoxicity, comprising as active ingredient the stereospecific (+) enantiomer, having (3S,4S) configuration of  DELTA 6 tetrahydrocannabinol type compounds. The compositions are particularly effective in alleviating and even preventing neurotoxicity due to acute injuries to the central nervous system, including mechanical trauma, compromised or reduced blood supply as may occur in cardiac arrest or stroke, or poisonings. They are also effective in the treatment of certain chronic degenerative diseases characterized by gradual neuronal loss.
Patent IL-116863-A0 (IL)
Title: An immunoenzymatic conjugate its preparation and use
IPC: G01N33/535
Filed: 1996-01-23
Abstract: PCT No. PCT/FR96/00113 Sec. 371 Date Nov. 22, 1996 Sec. 102(e) Date Nov. 22, 1996 PCT Filed Jan. 23, 1996 PCT Pub. No. WO96/23226 PCT Pub. Date Aug. 1, 1996Immunoenzymatic conjugate consisting of glycosylated labelling enzymes in copolymer form and substances having immunological activity. Method for the production of the conjugates according to the invention and use of the said conjugates in diagnostic kits.
Patent IL-118626-A0 (IL)
Title: Anti HBV antibody
IPC: C07K16/08
Filed: 1996-06-11
Abstract: Disclosed is a hybridoma cell line which produces human antibodies capable of binding to the hepatitis B virus surface antigen (HBVsAg), as well as antibodies produced by the cell line. Also disclosed are various uses of said antibodies in the prevention and treatment of HBV infection. Peripheral blood lymphocytes obtained from human donors having a high titer of anti HBVsAg antibodies are activated in vitro with pokeweed mitogen and then fused with heteromyeloma cells to generate hybridomas secreting human antibodies having a high affinity and specificity to HBVsAg.
Patent IL-125441-A0 (IL)
Title: Novel diphenyl stilbenes and pharmaceutical compositions thereof for treatment of cox-2 mediated diseases
IPC: C07C317/44
Filed: 1997-01-29
Abstract: The invention encompasses the novel compound of Formula (I) useful in the treatment of cyclooxygenase-2 mediated diseases. The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula (I).
Patent IL-126152-A0 (IL)
Title: Recombinant adenoviral vectors for human tumor gene therapy
IPC: C12N15/09
Filed: 1997-03-12
Abstract: A method for treating human tumours by gene therapy is disclosed. In particular, defective recombinant viruses with a sequence coding for a human tumour-specific antigen, and the use thereof for treating or preventing human tumours, as well as producing specific cytotoxic T-cells (CTLs) in vitro or ex vivo, are disclosed. Pharmaceutical compositions comprising said viruses, particularly in injectable form, are also disclosed.
Patent IL-132129-A0 (IL)
Title: Method for removing heavy metals from organic compounds
IPC: C07B63/02
Filed: 1998-05-04
Abstract: A method for removing heavy metals, selected from palladium, tin and nickel, from heavy metal complexes with thiazole compounds in aqueous or alcoholic solution, by precipitation as sulfides, characterised in that such solutions are treated with a water-soluble ammonium, alkaline or alkaline-earth sulfide.
Patent IL-134395-A0 (IL)
Title: Compressed nitroglycerin tablet and its method of manufacture
IPC: A61K9/20
Filed: 1998-09-16
Abstract: The present invention is directed to a stable nitroglycerin containing pharmaceutical composition, preferably a tablet which is prepared by direct compression technology. The formulation closely replicates the properties of nitroglycerin molded sublingual tablets (e.g. adequate disintegration and sublingual absorption), while reducing the problems experienced with compressed tablets (e.g. friability and weight variations). The stable tablets are characterized by a decreased migration of nitroglycerin, decreased potency loss, excellent content uniformity when stored. The preferred combination of components are: nitroglycerin/lactose dilution, hydrous lactose, glyceril monostearate, fumed silica, pregelantinized starch and calcium stearate. The preferred process employs direct compression technology to yield composition showing adequate disintegration, bioavailability and improved stability.
Patent IL-138665-A0 (IL)
Title: Peptide factor
IPC: C12N15/67
Filed: 1999-03-29
Abstract: The present invention relates to use of oxidised thymosin beta 4 in therapy, more particularly in the treatment of diseases or conditions associated with an inflammatory response or septic shock. The present invention also provides pharmaceutical formulations comprising oxidised thymosin beta 4 together with a suitable excipient.
Patent IL-145830-A0 (IL)
Title: Pharmaceutical compositions containing a compound which activates a receptor for glucagon-like peptide-1
IPC: A61K9/08
Filed: 2000-04-27
Abstract: Use of a composition which comprises a compound that activates a receptor for glucagon-like peptide-1 for the manufacture of a medicament for treating organ tissue injury caused by reperfusion of blood flow following a period of ischemia.